000			02040 a2200541 4500
005			20250513025655.0
264		0	_c19951129
008			199511s 0 0 eng d
022			_a0026-2862
024	7		_a10.1006/mvre.1995.1038 _2doi
040			_aNLM _beng _cNLM
100	1		_aMinnicozzi, M
245	0	0	_aPolyarginine and eosinophil-derived major basic protein increase microvascular permeability independently of histamine or nitric oxide release. _h[electronic resource]
260			_bMicrovascular research _cJul 1995
300			_a56-70 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aArginine _xanalogs & derivatives
650	0	4	_aBlood Proteins _xadministration & dosage
650	0	4	_aCapillary Permeability _xdrug effects
650	0	4	_aCell Degranulation _xdrug effects
650	0	4	_aCheek _xblood supply
650	0	4	_aCricetinae
650	0	4	_aDextrans _xpharmacokinetics
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aEosinophil Granule Proteins
650	0	4	_aFluorescein-5-isothiocyanate _xanalogs & derivatives
650	0	4	_aHistamine H1 Antagonists _xpharmacology
650	0	4	_aHistamine Release _xdrug effects
650	0	4	_aInflammation Mediators _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMast Cells _xdrug effects
650	0	4	_aNG-Nitroarginine Methyl Ester
650	0	4	_aNitric Oxide _xphysiology
650	0	4	_aNitric Oxide Synthase _xantagonists & inhibitors
650	0	4	_aPeptides _xadministration & dosage
650	0	4	_aPyrilamine _xpharmacology
650	0	4	_aRibonucleases
650	0	4	_aomega-N-Methylarginine
700	1		_aRamírez, M M
700	1		_aEgan, R W
700	1		_aGleich, G J
700	1		_aKobayashi, I
700	1		_aKim, D
700	1		_aDurán, W N
773	0		_tMicrovascular research _gvol. 50 _gno. 1 _gp. 56-70
856	4	0	_uhttps://doi.org/10.1006/mvre.1995.1038 _zAvailable from publisher's website
999			_c7476050 _d7476050